GobyMeds vs Livbetr
GobyMeds and Livbetr both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
GobyMeds
Best for: moving between compounded and brand without changing seller
Visit GobyMeds →Livbetr
Best for: dose-flat compounded GLP-1 pricing with a coach, if you check the renewal cycle before paying
Visit Livbetr →If you are choosing between GobyMeds and Livbetr, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Livbetr leads our six-part score, 8.5 to 8.3.
GobyMeds vs Livbetr price
GobyMeds and Livbetr start at the same figure, $99 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $99 a month; tirzepatide is cheaper at Livbetr ($129 a month vs $133 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, GobyMeds prices compounded injections and brand-name pens, while Livbetr prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, GobyMeds is the only one of the two with a brand-name price.
Where each one treats patients
Neither GobyMeds nor Livbetr publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
GobyMeds
$299 total for 12 weeks incl. medication, shipping, consultation, injection kit; JUMPSTART20 promo $279 total ($93/mo) — promo end-dated Dec 31 2025 but still displayed July 2026
$399 total / 12 weeks
$499 total / 12 weeks; JUMPSTART PROMO PRICE $439 ($146/month) shown under the higher-dose block
JUMPSTART20 promo $159
$399 total for 12 weeks incl. medication, shipping, consultation, injection kit; promo price shown unchanged at $399
$499 total / 12 weeks
$599 total / 12 weeks; JUMPSTART PROMO PRICE $479+ (price dependent on dose)
Primary pricing block says $299 (promo $279); a duplicated template block on the same page shows $349 — site inconsistency
Promo codes 'not valid on Zepbound and Wegovy'
Promo codes 'not valid on Zepbound and Wegovy'
Livbetr
$99 per billing cycle on the checkout page, the same at any dose, with supplies and overnight shipping included. Under the refund policy this plan bills on a 21-day cycle, which allows as many as 18 payments in the first year. A 12-month package is listed at $1,280, shown at $780 after a new-patient discount, in one payment.
$129 per billing cycle on the checkout page, the same at any dose, with supplies and overnight shipping included. Like the semaglutide plan, it renews every 21 days under the refund policy.
What each price covers
Both prices cover the clinician visit, the medication itself and shipping.
Livbetr's price also covers coaching, which GobyMeds does not claim.
GobyMeds is silent on lab work and coaching.
Livbetr is silent on lab work.
GobyMeds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Livbetr
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, Livbetr scores 8.5 and GobyMeds 8.3 out of 10.
Livbetr is stronger on support (8.5 vs 7.0).
Value, effectiveness, user experience, trust & safety and accessibility are within half a point.
GobyMeds
8.3/10
Livbetr
8.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GobyMeds nor Livbetr has an FDA warning letter on record with us.
Features & Coverage
| Feature | GobyMeds | Livbetr |
|---|---|---|
| Starting Price | $99/mo | $99/mo |
| Features | 2 features | ✓7 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | ✓ Yes |
| FDA Warning Letters | None | None |
About GobyMeds
GobyMeds is a low-cost telehealth seller. Compounded semaglutide is the only medication it offers.
Read our full GobyMeds review →About Livbetr
Livbetr is a cash-pay GLP-1 program that sells compounded semaglutide and tirzepatide at one price for every dose, with clinicians from the OpenLoop network and a 1:1 care coach. Its checkout lists the standard plan at $99 for semaglutide and $129 for tirzepatide, while the homepage advertises a lower sale price that checkout does not show. The refund policy says the short plan renews every 21 days rather than monthly, which means up to 18 charges in a year.
Read our full Livbetr review →Pros & Cons
GobyMeds
What we like
- Semaglutide costs $99 a month, 47% below the $188 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $133 a month, 47% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to GobyMeds
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Livbetr
What we like
- Semaglutide costs $99 a month, 47% below the $188 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $129 a month, 48% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits, shipping and coaching
- We found no FDA warning letters issued to Livbetr
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Livbetr wins this one, 8.5 to 8.3, above all for dose-flat compounded GLP-1 pricing with a coach, if you check the renewal cycle before paying. GobyMeds fits better if moving between compounded and brand without changing seller is your priority.
Choose GobyMeds if…
You want moving between compounded and brand without changing seller and an opening price near $99 a month.
Choose Livbetr if…
You want dose-flat compounded GLP-1 pricing with a coach, if you check the renewal cycle before paying and an opening price near $99 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
RxSpan MD
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $249/mo
Get started →Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →Strut Health
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →GobyMeds vs Livbetr: FAQ
Close alternatives to GobyMeds and Livbetr
- GobyMeds vs HeliMeds
- GobyMeds vs Aspire Health
- GobyMeds vs Good Girl Rx
- GobyMeds vs Measured
- Livbetr vs CoreAge Rx
- Livbetr vs bmiMD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.